Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 6
Journal homepage
41
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study

Yoshie KusunokiDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan
,
Nahoko TanakaDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan
,
Kaichi KanekoDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan
,
Tatsuhiro YamamotoDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan
,
Hirahito EndoDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, Japan
&
Shinichi KawaiDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541, JapanCorrespondence[email protected]
Pages 616-621 | Received 19 Jun 2009, Accepted 27 Jul 2009, Published online: 02 Jan 2014

References

  • McCune WJ. Immunosuppressive drug therapy. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 7th ed. Phila-delphia: Lippincott Williams & Wilikins; 2007. p. 1198–224.
  • Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immuno-suppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot. 1987;40: 1256–65.
  • Shapiro R, Jordan ML, Scantlebury VP, et al. The superiority of tacrolimus in renal transplant recipients—the Pittsburgh experi-ence. Clin Transpl, 1995: 199–205.
  • Kitahara K, Kawai S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2007;19:238–45.
  • Gremillion RB, Posever JO, Manek N, West JP, van Volen-Hoven RF. The role of tacrolimus in inflammatory bowel disease: a systematic review. J Rheumatol. 1999;26:2332–6.
  • Gonzalez-Lama Y, Gisbert JP, Mate J. The role of tacrolimus in inflammatory bowel disease: a systematic review. Dig Dis Sci. 2006;51:1833–40.
  • Konishi T, Yoshiyama Y, Takamori M, Saida T. Long-term treatment of generalised myasthenia gravis with FK506 (tacroli-mus). J Neurol Neurosurg Psychiatry. 2005;76:448–50.
  • Nagane Y, Utsugisawa K, Obara D, Kondoh R, Terayama Y. Efficacy of low-dose FK506 in the treatment of myasthenia gravis-a randomized pilot study. Eur Neurol. 2005;53: 146–50.
  • Mok CC, Tong KH, To CH, Siu YP, Au TC. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int. 2005;68:813–7.
  • Tse KC, Lam MF, Tang SC, Lai KN, Chan TM. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus. 2007;16:46–51.
  • Hochberg MC. Updating the American College of Rheumatology criteria for systemic lupus erythematosus. Arthritis Rheum. 1998;41:1725.
  • Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythe-matosus disease activity index 2000. J Rheumatol. 2002;29: 288–91.
  • Caplan L, Wolfe F, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and out-comes. J Rheumatol. 2007;34:696–705.
  • Duddridge M, Powell RJ. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis. 1997;56:690–2.
  • Maruoka H, Honda S, Takeo M, Koga T, Fukuda T, Aizawa H. Tacrolimus treatment for refractory lupus cystitis. Mod Rheu-matol. 2006;16:264–6.
  • Callen JP, Spencer LV, Burruss JB, Holtman J. Azathioprine. An effective, corticosteroid-sparing therapy for patients with recal-citrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol. 1991; 127:515–22.
  • Hahn BH, Kantor OS, Osterland CK. Azathioprine plus predni-sone compared with prednisone alone in the treatment of sys-temic lupus erythematosus. Report of a prospective controlled trial in 24 patients. Ann Intern Med. 1975;83: 597–605.
  • Mok CC. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review. Scand J Rheumatol. 2007;36:329–37.
  • Wong JM, Esdaile JM. Methotrexate in systemic lupus erythe-matosus. Lupus. 2005;14:101–5.
  • Caccavo D, Lagarià B, Mitterhofer AP, et al. Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum. 1997;40:27–35.
  • Isenberg DA, Snaith ML, Morrow WJ, et al. Cyclosporin A for the treatment of systemic lupus erythematosus. Int J. Immuno-pharmacol. 1981;3:163–9.
  • Tokuda M, Kurata N, Mizoguchi A, et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum. 1994;37:551–8.
  • Manger K, Kalden JR, Manger B. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol. 1996;35:669–75.
  • Dammacco F, Della Casa Alberighi 0, Ferraccioli G, Racanelli V, Casatta L, Bartoli E. Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus. Int J. Clin Lab Res. 2000;30:67–73.
  • Quartuccio L, Sacco S, Franzolini N, Perin A, Fenaccioli G, De Vita S. Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythema-tosus. Lupus. 2006;15:76–9.
  • Akimoto K, Kusunoki Y, Nishio S, Takagi K, Kawai S. Safety profile of tacrolimus in patients with rheumatoid arthritis. Clin Rheumatol. 2008;27:1393–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.